During COVID-19 peaks, some hospitals that experienced high patient volumes scrambled to meet the increased demand for renal replacement therapy (RRT). With nearly one-third of the sickest COVID patients requiring RRT, the pandemic’s early weeks saw supply shortages in some locales, stretching skilled personnel to the breaking point.
The choices some health systems made then could also signal a shift in the way RRT is delivered in the intensive care unit (ICU), favoring shorter bursts of therapy delivered by more